Saturday, July 11, 2026

Drug profile · INN

ly3209590

ly3209590 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — ly3209590
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

ly3209590 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ly3209590

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. I8H-MC-BDDG Phase 1 · Eli Lilly and · Type 2 Diabetes Mellitus
  2. LY3209590 (SC) Phase 1 · Eli Lilly and · Healthy
  3. 95% condensed proanthocyanidins from grape seed extract Unknown · United Therapeutics Europe · Iron Deficiency Anemia

Frequently asked questions

What is ly3209590?

ly3209590 is an FDA-listed pharmaceutical active ingredient.